Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).

Creators: Comi G; Patti F; Rocca MA; Mattioli FC; Amato MP; Gallo P; Centonze D; Pozzilli C; Saccà F; Bergh FT; Bartezaghi M; Turrini R; Filippi M; Patti F; Chisari CG; Marfia GA; Centonze D; Morra VB; Capra R; Pozzilli C; Bianchi V; Ghezzi A; Roscio M; Comi G; Sangalli F; Pietrolongo E; Francia A; Danni MC; Nocentini U; Bramanti P; Tedeschi G; Maimone D; Grimaldi LME; Scarpini EA; Uccelli A; Amato MP; Rottoli M; Ruggieri S; Trojano M; Bergamaschi R; Bergh FT; Buttmann M; Rieckmann P; Safavi A.

Others:: Comi, G; Patti, F; Rocca, Ma; Mattioli, Fc; Amato, Mp; Gallo, P; Centonze, D; Pozzilli, C; Saccà, F; Bergh, Ft; Bartezaghi, M; Turrini, R; Filippi, M; Patti, F; Chisari, Cg; Marfia, Ga; Centonze, D; Morra, Vb; Capra, R; Pozzilli, C; Bianchi, V; Ghezzi, A; Roscio, M; Comi, G; Sangalli, F; Pietrolongo, E; Francia, A; Danni, Mc; Nocentini, U; Bramanti, P; Tedeschi, G; Maimone, D; Grimaldi, Lme; Scarpini, Ea; Uccelli, A; Amato, Mp; Rottoli, M; Ruggieri, S; Trojano, M; Bergamaschi, R; Bergh, Ft; Buttmann, M; Rieckmann, P; Safavi, A.

Additional details